Back Login for AI Analysis

    NKTR (STOCKS)

    Nektar Therapeutics

    $38.480000
    -1.360000 (-3.41%)
    Prev close: $39.840000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Howard W. Robin
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $1,337.57M
    Employees
    61
    P/E (TTM)
    -5.66
    P/B (TTM)
    1.51
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    7
    Strong Buy
    8
    Buy
    3
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    		 $-1.23 $-2.02 +0.7943 +39.24%
    Mar 2026 (Q1)
    		 $-1.82 $-1.63 -0.1933 -11.88%
    Dec 2025 (Q4)
    		 $-1.78 $-2.52 +0.7436 +29.47%
    Sep 2025 (Q3)
    		 $-1.87 $-2.74 +0.8682 +31.71%